Home » Topics » Conferences

Conferences
RSS

Novel glucagon receptor antagonist with potential in treating type I/type II diabetes

Sep. 15, 1998

Pierre Fabre describes pharmacological profile of F-11440 -- new high-efficacy 5-HT1A agonist

Sep. 15, 1998

Potent mGluR1/mGluR5 receptor antagonist presented by Lilly at EFMC symposium

Sep. 15, 1998

SmithKline Beecham research leads to discovery of potent and selective 5-HT7 antagonists

Sep. 15, 1998

F-12682: new 5-HT1B/1D receptor inverse agonist for depression

Sep. 15, 1998

New Asta development candidate represents new type of PDE4 inhibitor

Sep. 15, 1998

Early clinical trial results reported for cilansetron at recent congress

Sep. 14, 1998

Nateglinide preclinical and clinical data featured at diabetes meeting

Sep. 14, 1998

Role of oral porcine spasmolytic polypeptide in GI disorders studied by Danish group

Sep. 14, 1998

Japanese researchers report progress in the gene therapy of gastric cancer

Sep. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...